Reflections from the APS Conference in Newcastle 2026 by the Science Chair 21 September 2026 APS was an inspiring, energising and deeply collaborative conference. Over the course of three remarkable days, we came together as a community to celebrate the very best of pharmaceutical science and, just as importantly, the people who make our discipline so vibrant and impactful. From the outstanding contributions of our Focus Groups and early-career researchers to our plenary and award lectures, the breadth and quality of the science on display were truly exceptional. We explored everything from fundamental scientific discovery to the complex challenges of formulation, delivery, manufacturing and translation to patient benefit. What stood out throughout was not only the excellence of the research, but the shared commitment, curiosity and generosity that define our [...]

APS Announces PharmSci 2027 Dates, Location and Scientific Programme Lead 15 September 2026 The APS is pleased to announce the PharmSci 2027 details as follows: Dates and Location 6-8 September 2027 Strathclyde, Glasgow, Scotland, UK Scientific Programme Lead Ali Rajabi-Siahboomi, PhD Message from PharmSci 2027 Scientific Programme Lead We are in an exciting period in pharmaceutical sciences, where advances in artificial intelligence (AI), data science, advanced manufacturing and focus on innovation are transforming how we discover, develop, make and deliver medicines. With this in mind, we have chosen the theme for PharmSci 2027 as: Accelerating Access to Medicines Innovation + Translation = Global Patient Impact To me, this theme reflects the true [...]

APS Announces PharmSci 2026 Award Lecture Winners 13 July 2026 The APS is pleased to announce the PharmSci 2026 Award Lecture Winners. We received a large number of applications and would like to thank all the applicants for their support. We are pleased to announce the winners as follows: APS Award Lecture Bruno C. Hancock, PhD. Vice President, Aleurites LLC Bruno C. Hancock is a pharmaceutical industry consultant and the former head of materials science at Pfizer Inc. He holds a BPharm from the University of Bath, UK and a Ph.D. in Pharmaceutical Technology from the University of Bradford, UK. Before working as a consultant, he held a post-doctoral research appointment at the University of [...]

Congratulations to Goda Pyragaite and Moiz Ali, winners of the APS Research Project Prizes at London Metropolitan University... 1 July 2026 Goda Pyragaite Moiz Ali The Academy of Pharmaceutical Sciences (APS) is delighted to announce Goda Pyragaite and Moiz Ali as the winners of the APS Research Project Prizes at London Metropolitan University. These awards recognise exceptional research excellence across both undergraduate and postgraduate study. Goda Pyragaite was selected as the prize winner for the BSc Pharmaceutical Science programme, impressing assessors with the depth of her scientific understanding and the clarity and originality of her project work. Her research demonstrated strong analytical skills and a professional approach that set her apart from her peers. Moiz Ali received the award for the MSc Pharmaceutical Science programme. [...]

For 25 years, the Academy of Pharmaceutical Sciences (APS) has been the UK’s professional home for Pharmaceutical Scientists... 22 June 2026 For 25 years, the Academy of Pharmaceutical Sciences (APS) has been the UK’s professional home for Pharmaceutical Scientists - a global community dedicated to improving the development, delivery and understanding of medicines for the benefit of patients. As a not‑for‑profit organisation, APS exists to champion innovation, nurture opportunity and elevate excellence across the pharmaceutical sciences. We represent individuals and organisations from around the world, supporting them throughout their professional journey and promoting the vital role Pharmaceutical Scientists play in the research, development, manufacture and regulation of medicines, and in understanding how they are used in patients. Over the past quarter‑century, our work has been guided by four enduring [...]

Biopharmaceutics Focus Group - Meeting report from “Physiologically Based Pharmacokinetic Modelling (PBBM) - Best Scientific Practices to Define Drug Product Performance: Latest Regulatory and Industry Perspectives” 28 May 2026 Biopharmaceutics Focus Group The APS Biopharmaceutics Focus Group are pleased to share that the meeting report from the 2-day meeting on “Physiologically Based Pharmacokinetic Modelling (PBBM) - Best Scientific Practices to Define Drug Product Performance: Latest Regulatory and Industry Perspectives” and hosted by MHRA in London, UK is now available ((Physiologically Based Biopharmaceutics Modelling—Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report)). Around 80 scientists from industrial, academic, regulatory, and software companies came together to discuss the latest developments in PBBM and to debate key topics relevant to the establishment of [...]

In Memoriam - Dr Bill Dawson 18 March 2026 APS was very sorry to learn that Dr Bill Dawson died suddenly... APS was very sorry to learn that Dr Bill Dawson died suddenly on 20 February. Bill was a founder member of APS, past Chairman, Past Board member and past Advisory Board Member. He also set up the accreditation process and was a member of the accreditation team. Bill had a long and distinguished career as a pharmaceutical scientist and will be sadly missed.

APS Opens Applications for 2026 Fellowships 16 January 2026 The APS is delighted to announce that applications for 2026 APS Fellowships are now open. A Fellowship is the highest and most prestigious honour awarded by the APS to Members each year in recognition of their contribution to the Academy and their accomplishment and impact in any sector of the Pharmaceutical Sciences. Recipients of the APS Fellowship(s) will be recognised at the PharmSci Conference being held in Newcastle from 7th - 9th September 2026. Find out more and apply here. NOTE: Application submission deadline is 31st May 2026

APS Announces New Treasurer 29 December 2025 The APS is delighted to announce that the new APS Treasurer is Kieran Sproston. Kieran Sproston MPharm Senior Scientist SEDA Pharmaceutical Development Services Speaking on his appointment as incoming Treasurer of APS, Kieran said: “I have been involved with APS since my undergraduate days and have greatly benefited from the many activities and learning opportunities the organization provides. I am grateful for the chance to continue supporting APS in the role of Treasurer. I would also like to extend my sincere thanks to Bob Clay for his outstanding contributions during his tenure as Treasurer and for generously sharing his knowledge and guidance as I step into this position."

APS is Awarded the FIP Seal for Accreditation Agencies 03 December 2025 The FIP Bureau, with the support of the FIP Consortium, has recently approved the awarding of the FIP Seal for Accreditation Agencies to the APS... The FIP Bureau, with the support of the FIP Consortium, has recently approved the awarding of the FIP Seal for Accreditation Agencies to the APS. The APS successfully met the rigorous FIP Seal criteria, demonstrating strong quality, relevance, and alignment with FIP’s global mission to advance pharmacy and the FIP Development Goals. "As Chair of the APS, I am delighted that we have achieved the FIP Seal. This demonstrates that APS aligns with FIP’s mission to advance pharmacy worldwide and demonstrates assurance of quality in accreditation processes. It [...]